首页>
外国专利>
PHARMACEUTICAL COMBINATION OF Atypical Antipsychotic and NMDA Modulator for the Treatment of Schizophrenia, Bipolar Disorder, Cognitive Disorder and Clinical Depression
PHARMACEUTICAL COMBINATION OF Atypical Antipsychotic and NMDA Modulator for the Treatment of Schizophrenia, Bipolar Disorder, Cognitive Disorder and Clinical Depression
展开▼
机译:非典型抗精神病药和NMDA调节剂的药物组合治疗精神分裂症,双相情感障碍,认知障碍和临床抑郁症
展开▼
页面导航
摘要
著录项
相似文献
摘要
This disclosure features combinations of NMDA modulators and atypical antipsychotics. The disclosure provides for example, methods of treating schizophrenia, bipolar disorder, and/or cognitive impairment disorder in a patient in need thereof, comprising administering e.g., rapastinel and an atypical antipsychotic.
展开▼